Interleukin-10 promoter polymorphisms in patients with hepatitis B virus infection or hepatocellular carcinoma in Chinese Han ethnic population

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 1, 2006, Pages 60-64

  Wang, Juan ^a,b   Ni, Hong ^a   Chen, Li ^a   Song, Wen Qin ^a  

^a NANKAI UNIVERSITY   (China)

^b SHENZHEN UNIVERSITY   (China)

Author keywords

Carcinoma; Hepatitis B virus; Hepatocellular; Interleukin 10; Polymerase chain reaction single strand conformation polymorphism; Polymorphisms on promoter region

Indexed keywords

INTERLEUKIN 10; TRANSCRIPTION FACTOR GATA 2;

ARTICLE; CHINESE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENE INSERTION; GENE SEQUENCE; GENETIC POLYMORPHISM; HEPATITIS B; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS PATHOGENESIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHINA; DNA; FEMALE; HEPATITIS B; HUMANS; INTERLEUKIN-10; LIVER NEOPLASMS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS);

EID: 33644527554     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wang J, Ni H, Chen L, Liu YX, Chen CB, Song WQ. Preparation and analysis of CSNP chip on hepatocellular carcinoma-related genes. Hepatobiliary Pancreat Dis Int 2005; 4: 398-402.
2. Moore KW, O'Grarra A, De-Waal-malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-190.
3. Spits H, Malefyt RW. Functional characterization of human IL-10. Int Arch Allergy Immunol 1992;99:8-15.
4. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 1999; 22:239-247.
5. Redpath S, Ghazal P, Gascoigne NR. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001;9:86-92.
6. Jia HY, Du J, Zhu SH, Ma YJ, Chen HY, Yang BS, et al. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 2002;1:378-382.
7. Rees LE, Wood NA, Gillespie KM, Lai KN, Gaston K, Mathieson PW. The interleukine-10 -1082A/G polymorphism: allene frequency in different populations and functional significance. Cell Mol Life Sci 2002;59:560-569.
8. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukine-10 gene promoter. Eur J Immunogenet 1997;24: 1-8.
9. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003; 12: 901-906.
10. Havranek E, Howell WM, Fussell HM, Whelan JA, Whelan MA, Pandha HS. An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. J Urol 2005;173:709-712.
11. Niu JY, Shen HB. Application and purification of DNA from clotted blood. J Nanjing Med University 2000;20:389-390.
12. Pyo CW, Hur SS, Kim YK, Choi FM, Hong YS, Kim DW, et al. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-γ genes in the Korean population. Human Immunol 2003;64:979-989.
13. Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999;30:851-856.
14. Hu PC, Xu YJ, Zhang ZX, Xie JG. Polymorphism of interleukin-10 gene promoter and its association with susceptibility to chronic obstructive pulmonary disease in Chinese Han people. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003;20: 504-507.
15. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002;97: 2086-2092.
16. Almeras L, Meresse B, Seze J, De Lefranc D, Dubucquoi S, Fajardy I, et al. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression. Eur Cytokine Net 2002;13:200-206.
17. Han XC, Zhang YC, Wang Y, Jia NM. Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int 2003;2:135-138.
18. Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, Dolcetti R, et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 2005;165:40-46.
19. Chen QB, Fan LY, Zhong PQ, Tu XQ, Yuan Y, Zhu Y, et al. A study on the relationship between interleukin-10 promoter polymorphism and autoimmune liver disease. Zhonghua Gan Zang Bing Za Zhi 2004;12:356-358.
20. Napoli J, Bishop GA, McGuinness pH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996 24:759-765.
21. Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K, et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998;28: 1607-1615.